stoxline Quote Chart Rank Option Currency Glossary
  
American Well Corporation (AMWL)
9.34  0.83 (9.75%)    09-13 16:00
Open: 8.58
High: 9.505
Volume: 66,292
  
Pre. Close: 8.51
Low: 8.55
Market Cap: 140(M)
Technical analysis
2024-09-13 4:31:55 PM
Short term     
Mid term     
Targets 6-month :  11.1 1-year :  12.96
Resists First :  9.5 Second :  11.1
Pivot price 8.27
Supports First :  8.42 Second :  7.75
MAs MA(5) :  8.4 MA(20) :  8.36
MA(100) :  8.61 MA(250) :  16.65
MACD MACD :  0 Signal :  -0.1
%K %D K(14,3) :  57.9 D(3) :  37.5
RSI RSI(14): 60.9
52-week High :  31.6 Low :  5
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ AMWL ] has closed Bollinger Bands are 38.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 9.51 - 9.54 9.54 - 9.57
Low: 8.47 - 8.5 8.5 - 8.54
Close: 9.28 - 9.33 9.33 - 9.39
Company Description

American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Headline News

Sat, 14 Sep 2024
While institutions invested in American Well Corporation (NYSE:AMWL) benefited from last week's 18% gain, retail investors stood to gain the most - Simply Wall St

Fri, 06 Sep 2024
American Well Corp EVP sells shares worth over $24k - Investing.com

Wed, 31 Jul 2024
American Well (AMWL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Wed, 24 Jul 2024
Even With A 26% Surge, Cautious Investors Are Not Rewarding American Well Corporation's (NYSE:AMWL) Performance Completely - Simply Wall St

Tue, 16 Jul 2024
American Well Corp announces 1-for-20 reverse stock split - Investing.com

Fri, 28 Jun 2024
Amwell Announces Reverse Stock Split | AMWL Stock News - StockTitan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Shares Out 13 (M)
Shares Float 11 (M)
Held by Insiders 5.2 (%)
Held by Institutions 54.4 (%)
Shares Short 654 (K)
Shares Short P.Month 423 (K)
Stock Financials
EPS -21.08
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 24.32
Profit Margin -120.5 %
Operating Margin -83.5 %
Return on Assets (ttm) -23.1 %
Return on Equity (ttm) -61 %
Qtrly Rev. Growth 0.5 %
Gross Profit (p.s.) 0
Sales Per Share 19.1
EBITDA (p.s.) -15.68
Qtrly Earnings Growth 0 %
Operating Cash Flow -161 (M)
Levered Free Cash Flow -83 (M)
Stock Valuations
PE Ratio -0.45
PEG Ratio -0.1
Price to Book value 0.38
Price to Sales 0.48
Price to Cash Flow -0.78
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android